Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischemic stroke

被引:262
作者
Trouillas, P
von Kummer, R
机构
[1] Hop Neurol, Cerebrovasc Unit, F-69003 Lyon, France
[2] Univ Hosp, Dept Neuroradiol, Dresden, Germany
关键词
cerebral infarction; hemostasis; heparin; intracranial hemorrhage; thrombolysis;
D O I
10.1161/01.STR.0000196942.84707.71
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose - Brain hemorrhage after ischemic stroke is a serious complication of treatment; however, its pathology is poorly understood. A classification based on brain imaging may help to better understand and avoid causal factors. Methods - Review of the results of controlled randomized trials and the available literature. Results - Hemorrhagic infarctions have no impact on clinical outcome and are probably not associated with the thrombolytic itself and the type of reperfusion strategy. They are associated with the extent of ischemic damage and most probably to an ischemic vasculopathy. Parenchymal hematomas are often clinically relevant. Their incidence is affected by the thrombolytic itself, the type, and probably the time point of reperfusion strategy. The loss of hemostatic control seems important in their pathogenesis. Extraischemic hematomas (remote from the infarct), unique or multiple, suggest pre-existing brain pathology, especially cerebral amyloid angiopathy. Conclusions - The radiological description of 3 different types of brain hemorrhage is useful to better understand the specific pathology and the impact on clinical outcome. It may help to avoid clinically relevant brain hemorrhages.
引用
收藏
页码:556 / 561
页数:6
相关论文
共 46 条
  • [1] Hemorrhagic transformation of ischemic brain tissue -: Asymptomatic or symptomatic?
    Berger, C
    Fiorelli, M
    Steiner, T
    Schäbitz, WR
    Bozzao, L
    Bluhmki, E
    Hacke, W
    von Kummer, R
    [J]. STROKE, 2001, 32 (06) : 1330 - 1335
  • [2] Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke
    Brott, T
    Broderick, J
    Kothari, R
    ODonoghue, M
    Barsan, W
    Tomsick, T
    Spilker, J
    Miller, R
    Sauerbeck, L
    Farrell, J
    Kelly, J
    Perkins, T
    Miller, R
    McDonald, T
    Rorick, M
    Hickey, C
    Armitage, J
    Perry, C
    Thalinger, K
    Rhude, R
    Schill, J
    Becker, PS
    Heath, RS
    Adams, D
    Reed, R
    Klei, M
    Hughes, A
    Anthony, J
    Baudendistel, D
    Zadicoff, C
    Rymer, M
    Bettinger, I
    Laubinger, P
    Schmerler, M
    Meiros, G
    Lyden, P
    Dunford, J
    Zivin, J
    Rapp, K
    Babcock, T
    Daum, P
    Persona, D
    Brody, M
    Jackson, C
    Lewis, S
    Liss, J
    Mahdavi, Z
    Rothrock, J
    Tom, T
    Zweifler, R
    [J]. STROKE, 1997, 28 (11) : 2109 - 2118
  • [3] ANALYSIS OF COAGULATION AND FIBRINOLYSIS DURING INTRAVENOUS-INFUSION OF RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    COLLEN, D
    BOUNAMEAUX, H
    DECOCK, F
    LIJNEN, HR
    VERSTRAETE, M
    [J]. CIRCULATION, 1986, 73 (03) : 511 - 517
  • [4] Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke
    del Zoppo, GJ
    Von Kummer, R
    Hamann, GF
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 65 (01) : 1 - 9
  • [5] Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator
    Derex, L
    Hermier, M
    Adeleine, P
    Pialat, JB
    Wiart, M
    Berthezène, Y
    Philippeau, F
    Honnorat, J
    Froment, JC
    Trouillas, P
    Nighoghossian, N
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (01) : 70 - 75
  • [6] Thrombolysis for ischemic stroke in patients with old microbleeds on pretreatment MRI
    Derex, L
    Nighoghossian, N
    Hermier, M
    Adeleine, P
    Philippeau, F
    Honnorat, J
    Yilmaz, H
    Dardel, P
    Froment, JC
    Trouillas, P
    [J]. CEREBROVASCULAR DISEASES, 2004, 17 (2-3) : 238 - 241
  • [7] Hemorrhagic transformation within 36 hours of a cerebral infarct - Relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort
    Fiorelli, M
    Bastianello, S
    von Kummer, R
    del Zoppo, GJ
    Larrue, V
    Lesaffre, E
    Ringleb, AP
    Lorenzano, S
    Manelfe, C
    Bozzao, L
    [J]. STROKE, 1999, 30 (11) : 2280 - 2284
  • [8] Intra-arterial prourokinase for acute ischemic stroke - The PROACT II study: A randomized controlled trial
    Furlan, A
    Higashida, R
    Wechsler, L
    Gent, M
    Rowley, H
    Kase, C
    Pessin, M
    Ahuja, A
    Callahan, F
    Clark, WM
    Silver, F
    Rivera, F
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21): : 2003 - 2011
  • [9] INTRACEREBRAL HEMORRHAGE, CEREBRAL INFARCTION, AND SUBDURAL-HEMATOMA AFTER ACUTE MYOCARDIAL-INFARCTION AND THROMBOLYTIC THERAPY IN THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION STUDY - THROMBOLYSIS IN MYOCARDIAL-INFARCTION, PHASE-II, PILOT AND CLINICAL-TRIAL
    GORE, JM
    SLOAN, M
    PRICE, TR
    RANDALL, AMY
    BOVILL, E
    COLLEN, D
    FORMAN, S
    KNATTERUD, GL
    SOPKO, G
    TERRIN, ML
    [J]. CIRCULATION, 1991, 83 (02) : 448 - 459
  • [10] STROKE AFTER THROMBOLYSIS - MORTALITY AND FUNCTIONAL OUTCOMES IN THE GUSTO-I TRIAL
    GORE, JM
    GRANGER, CB
    SIMOONS, ML
    SLOAN, MA
    WEAVER, D
    WHITE, HD
    BARBASH, GI
    VANDEWERF, F
    AYLWARD, PE
    TOPOL, EJ
    CALIFF, RM
    [J]. CIRCULATION, 1995, 92 (10) : 2811 - 2818